Advances in Ozone-Based Inactivation of SARS-CoV-2: An Updated Review
Abstract
1. Introduction
2. Ozone Characteristics
3. Factors Influencing Ozone Disinfection
4. Ozone Virucidal Mechanism
5. Inactivation of SARS-CoV-2 by Gaseous Ozone in Environments and on Surfaces
6. Inactivation of SARS-CoV-2 by Ozonated Water and Influencing Factors
7. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Mofijur, M.; Fattah, I.M.R.; Alam, M.A.; Islam, A.B.M.S.; Ong, H.C.; Rahman, S.M.A.; Najafi, G.; Ahmed, S.F.; Uddin, M.A.; Mahlia, T.M.I. Impact of COVID-19 on the social, economic, environmental, and energy domains: Lessons learned from a global pandemic. Sustain. Prod. Consum. 2021, 26, 343–359. [Google Scholar] [CrossRef]
- Caggiano, G.; Triggiano, F.; Apollonio, F.; Diella, G.; Lopuzzo, M.; D’Ambrosio, M.; Fasano, F.; Stefanizzi, P.; Sorrenti, G.T.; Magarelli, P.; et al. SARS-CoV-2 RNA and supermarket surfaces: A real or presumed threat? Int. J. Environ. Res. Public Health 2021, 18, 9404. [Google Scholar] [CrossRef]
- Petrillo, S.; Carrà, G.; Bottino, P.; Zanotto, E.; De Santis, M.C.; Margaria, J.P.; Giorgio, A.; Mandili, G.; Martini, M.; Cavallo, R.; et al. A novel multiplex qRT-PCR assay to detect SARS-CoV-2 infection: High sensitivity and increased testing capacity. Microorganisms 2020, 8, 1064. [Google Scholar] [CrossRef]
- Chia, P.Y.; Coleman, K.K.; Tan, Y.K.; Ong, S.W.X.; Gum, M.; Lau, S.K.; Lim, X.F.; Lim, A.S.; Sutjipto, S.; Lee, P.H.; et al. Singapore 2019 Novel Coronavirus Outbreak Research Team. Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients. Nat. Commun. 2020, 11, 2800. [Google Scholar] [CrossRef] [PubMed]
- Mondelli, M.U.; Colaneri, M.; Seminari, E.M.; Baldanti, F.; Bruno, R. Low risk of SARS-CoV-2 transmission by fomites in real-life conditions. Lancet Infect. Dis. 2021, 21, e112. [Google Scholar] [CrossRef]
- Harvey, A.P.; Fuhrmeister, E.R.; Cantrell, M.E.; Pitol, A.K.; Swarthout, J.M.; Powers, J.E.; Nadimpalli, M.L.; Julian, T.R.; Pickering, A.J. Longitudinal monitoring of SARS-CoV-2 RNA on high-touch surfaces in a community setting. Environ. Sci. Technol. Lett. 2021, 8, 168–175. [Google Scholar] [CrossRef]
- Liu, Y.; Li, T.; Deng, Y.; Liu, S.; Zhang, D.; Li, H.; Wang, X.; Jia, L.; Han, J.; Bei, Z. Stability of SARS-CoV-2 on environmental surfaces and in human excreta. J. Hosp. Infect. 2021, 107, 105–107. [Google Scholar] [CrossRef]
- Van Doremalen, N.; Bushmaker, T.; Morris, D.H.; Holbrook, M.G.; Gamble, A.; Williamson, B.N.; Tamin, A.; Harcourt, J.L.; Thornburg, N.J.; Gerber, S.I. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N. Engl. J. Med. 2020, 382, 1564–1567. [Google Scholar] [CrossRef] [PubMed]
- Jayaweera, M.; Perera, H.; Gunawardana, B.; Manatunge, J. Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy. Environ. Res. 2020, 188, 109819. [Google Scholar] [CrossRef] [PubMed]
- Aboubakr, H.A.; Sharafeldin, T.A.; Goyal, S.M. Stability of SARS-CoV and other coronaviruses in the environment and on common touch surfaces and the influence of climatic conditions: A review. Transbound. Emerg. Dis. 2020, 68, 296–312. [Google Scholar] [CrossRef]
- Irie, M.S.; Dietrich, L.; Souza, G.L.; Soares, P.B.F.; Moura, C.C.G.; Silva, G.R.D.; Paranhos, L.R. Ozone disinfection for viruses with applications in healthcare environments: A scoping review. Braz. Oral. Res. 2022, 36, e006. [Google Scholar] [CrossRef] [PubMed]
- Gola, M.; Caggiano, G.; De Giglio, O.; Napoli, C.; Diella, G.; Carlucci, M.; Carpagnano, L.F.; D’Alessandro, D.; Joppolo, C.M.; Capolongo, S.; et al. SARS-CoV-2 indoor contamination: Considerations on anti-COVID-19 management of ventilation systems and finishing materials in healthcare facilities. Ann. Ig. 2021, 33, 381–392. [Google Scholar] [CrossRef]
- Rangel, K.; De-Simone, S.G. Acinetobacter baumannii during COVID-19: What is the real pandemic? Pathogens 2023, 12, 41. [Google Scholar] [CrossRef] [PubMed]
- Tregoning, J.S.; Wang, Z.; Sridhar, S.; Shattock, R.J.; DeRosa, F. Immunology of RNA-based vaccines: The critical interplay between inflammation and expression. Mol. Ther. 2025, 8, 1–56. [Google Scholar] [CrossRef]
- Moghadas, S.M.; Vilches, T.N.; Zhang, K.; Wells, C.R.; Shoukat, A.; Singer, B.H.; Meyers, L.A.; Neuzil, K.M.; Langley, J.M.; Fitzpatrick, M.C.; et al. The impact of vaccination on COVID-19 outbreaks in the United States. Clin. Infect. Dis. 2021, 73, 2257–2264. [Google Scholar] [CrossRef]
- Tenforde, M.W.; Olson, S.M.; Self, W.H.; Talbot, H.K.; Lindsell, C.J.; Steingrub, J.S.; Shapiro, N.I.; Ginde, A.A.; Douin, D.J.; Prekker, M.E.; et al. Effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 among hospitalized adults aged ≥65 years—United States January-March 2021. MMWR Morb. Mortal. Wkly. Rep. 2021, 70, 674–679. [Google Scholar] [CrossRef]
- Leung, K.; Shum, M.H.; Leung, G.M.; Lam, T.T.; Wu, J.T. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom: October to November 2020. Euro Surveill. 2021, 26, 2002106, Erratum in: Euro Surveill. 2021, 26, 210121a. https://doi.org/10.2807/1560-7917.ES.2021.26.3.210121a. [Google Scholar] [CrossRef]
- Makoni, M. South Africa responds to new SARS-CoV-2 variant. Lancet 2021, 397, 267. [Google Scholar] [CrossRef]
- Dewey, H.M.; Jones, J.M.; Keating, M.R.; Budhathoki-Uprety, J. Increased use of disinfectants during the COVID-19 pandemic and its potential impacts on health and safety. ACS Chem. Health Saf. 2022, 29, 27–38. [Google Scholar] [CrossRef]
- Manjunath, S.N.; Sakar, M.; Katapadi, M.; Geetha Balakrishna, R. Recent case studies on the use of ozone to combat coronavirus: Problems and perspectives. Environ. Technol. Innov. 2021, 21, 101313. [Google Scholar] [CrossRef] [PubMed]
- Rangel, K.; Cabral, F.O.; Lechuga, G.C.; Carvalho, J.P.R.S.; Villas-Bôas, M.H.S.; Midlej, V.; De-Simone, S.G. Detrimental effect of ozone on pathogenic bacteria. Microorganisms 2022, 10, 40. [Google Scholar] [CrossRef] [PubMed]
- Rangel, K.; Cabral, F.O.; Lechuga, G.C.; Carvalho, J.P.R.S.; Villas-Bôas, M.H.S.; Midlej, V.; De-Simone, S.G. Potent activity of high concentrations of chemical ozone against antibiotic-resistant bacteria. Molecules 2022, 27, 3998. [Google Scholar] [CrossRef]
- Liu, J.; Yue, P.; Huang, L.; Zhao, M.; Kang, X.; Liu, X. Styrene removal with an acidic biofilter with four packing materials: Performance and fungal bioaerosol emissions. Environ. Res. 2020, 191, 110154. [Google Scholar] [CrossRef]
- Zanardi, I.; Borrelli, E.; Valacchi, G.; Travagli, V.; Bocci, V. Ozone: A multifaceted molecule with unexpected therapeutic activity. Curr. Med. Chem. 2015, 23, 304–314. [Google Scholar] [CrossRef]
- Shen, J.; Gao, Z. Ozone removal on building material surface: A literature review. Build. Environ. 2018, 134, 205–217. [Google Scholar] [CrossRef]
- Istituto Superiore di Sanità, Focus on the Professional Use of Ozone Also in Reference to COVID-19 Working Group ISS-INAIL. 2020. Available online: https://www.iss.it/en/pubblicazioni-focus/-/asset_publisher/GIDBUf2rmBr2/content/id/5524886 (accessed on 15 July 2025).
- Albert, S.; Amarilla, A.A.; Trollope, B.; Sng, J.D.J.; Setoh, Y.X.; Deering, N.; Modhiran, N.; Weng, S.H.; Melo, M.C.; Hutley, N.; et al. Assessing the potential of unmanned aerial vehicle spraying of aqueous ozone as an outdoor disinfectant for SARS-CoV-2. Environ. Res. 2021, 196, 110944. [Google Scholar] [CrossRef] [PubMed]
- Criscuolo, E.; Diotti, R.A.; Ferrarese, R.; Alippi, C.; Viscardi, G.; Signorelli, C.; Mancini, N.; Clementi, M.; Clementi, N. Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials. Emerg. Microbes Infect. 2021, 10, 206–210. [Google Scholar] [CrossRef]
- Martínez-Sánchez, G.; Schwartz, A.; Donna, V.D. Potential cytoprotective activity of ozone therapy in SARS-CoV-2/COVID-19. Antioxidants 2020, 9, 389. [Google Scholar] [CrossRef]
- Yousefi, B.; Banihashemian, S.Z.; Feyzabadi, Z.K.; Hasanpour, S.; Kokhaei, P.; Abdolshahi, A.; Emadi, A.; Eslami, M. Potential therapeutic effect of oxygen-ozone in controlling of COVID-19 disease. Med. Gas Res. 2022, 12, 33–40. [Google Scholar] [CrossRef]
- Shang, W.; Wang, Y.; Wang, G.; Han, D. Benefits of ozone on mortality in patients with COVID-19: A systematic review and meta-analysis. Complement. Ther. Med. 2023, 72, 102907. [Google Scholar] [CrossRef] [PubMed]
- Jafari-Oori, M.; Vahedian-Azimi, A.; Ghorbanzadeh, K.; Sepahvand, E.; Dehi, M.; Ebadi, A.; Izadi, M. Efficacy of ozone adjuvant therapy in COVID-19 patients: A meta-analysis study. Front. Med. 2022, 10, 1037749. [Google Scholar] [CrossRef]
- Budi, D.S.; Rofananda, I.F.; Pratama, N.R.; Sutanto, H.; Hariftyani, A.S.; Desita, S.R.; Rahmasari, A.Z.; Asmarawati, T.P.; Waskito, L.A.; Wungu, C.D.K. Ozone as an adjuvant therapy for COVID-19: A systematic review and meta-analysis. Int. Immunopharmacol. 2022, 110, 109014. [Google Scholar] [CrossRef]
- Cenci, A.; Macchia, I.; La Sorsa, V.; Sbarigia, C.; Di Donna, V.; Pietraforte, D. Mechanisms of action of ozone therapy in emerging viral diseases: Immunomodulatory effects and therapeutic advantages with reference to SARS-CoV-2. Front. Microbiol. 2022, 21, 871645. [Google Scholar] [CrossRef]
- Smith, N.L.; Wilson, A.L.; Gandhi, J.; Vatsia, S.; Khan, S.A. Ozone therapy: An overview of pharmacodynamics current research and clinical utility. Med. Gas. Res. 2017, 7, 212–219. [Google Scholar] [CrossRef] [PubMed]
- Bocci, V.; Valacchi, G.; Corradeschi, F.; Fanetti, G. Studies on the biological effects of ozone: 8. Effects on the total antioxidant status and interleukin-8 production. Mediat. Inflamm. 1998, 7, 313–317. [Google Scholar] [CrossRef]
- Ranaldi, G.T.; Villani, E.R.; Franza, L. Rationale for ozone-therapy as adjuvant therapy in COVID-19: A narrative review. Med. Gas. Res. 2020, 10, 134–138. [Google Scholar] [CrossRef]
- Martins, R.B.; Castro, I.A.; Pontelli, M.; Souza, J.P. SARS-CoV-2 inactivation by ozonated water: A preliminary alternative for environmental disinfection. Ozone Sci. Eng. 2021, 43, 108–111. [Google Scholar] [CrossRef]
- Inagaki, H.; Akatsuki, S.; Sudaryatma, P.E.; Sugiyamaa, H.; Okabayash, Y.; Fujimoto, S. Rapid inactivation of SARS-CoV-2 with ozonated water. Ozone Sci. Eng. 2021, 43, 208–212. [Google Scholar] [CrossRef]
- El Meligy, O.A.; Elemam, N.M.; Talaat, I.M. Ozone therapy in medicine and dentistry: A review of the literature. Dent. J. 2023, 11, 187. [Google Scholar] [CrossRef] [PubMed]
- Hudson, J.B.; Sharma, M.; Vimalanathan, S. Development of a practical method for using ozone gas as a virus decontaminating agent. Ozone Sci. Eng. 2009, 31, 216–223. [Google Scholar] [CrossRef]
- Morrison, C.; Atkinson, A.; Zamyadi, A.; Kibuye, F.; McKie, M.; Hogard, S.; Mollica, P.; Jasim, S.; Wert, E.C. Critical review and research needs of ozone applications related to virus inactivation: Potential implications for SARS-CoV-2. Ozone Sci. Eng. 2021, 43, 2–20. [Google Scholar] [CrossRef]
- Hoigne, L.; Baderm, H. Ozonation of water: Selectivity and rate of oxidation of solutes. Ozone Sci. Eng. 1979, 1, 73–85. [Google Scholar] [CrossRef]
- Viebahn-Haensler, R.; León Fernández, O.S. Ozone in medicine. The low-dose ozone concept and its basic biochemical mechanisms of action in chronic inflammatory diseases. Int. J. Mol. Sci. 2021, 22, 7890. [Google Scholar] [CrossRef]
- Kumar, G.D.; Williams, R.C.; Sumnerm, S.S.; Eifertm, J.D. Effect of ozone and ultraviolet light on Listeria monocytogenes populations in fresh and spent chill brines. Food Cont. 2016, 59, 172–177. [Google Scholar] [CrossRef]
- Guzel-Seydim, Z.B.; Greene, A.K.; Seydim, A.C. Use of ozone in the food industry. LWT-Food Sci. Technol. 2004, 37, 453–460. [Google Scholar] [CrossRef]
- Joseph, C.G.; Farm, Y.Y.; Taufiq-Yap, Y.H.; Pang, C.K.; Nga, J.L.H.; Puma, G.L. Ozonation treatment processes for the remediation of detergent wastewater: A comprehensive review. J. Environ. Chem. Eng. 2021, 9, 106099. [Google Scholar] [CrossRef]
- Mousazadeh, M.; Kabdaşlı, I.; Khademi, S.; Sandoval, M.A.; Moussavi, S.P.; Malekdar, F.; Gilhotra, V.; Hashemi, M.; Dehghani, M.H. A critical review on the existing wastewater treatment methods in the COVID-19 era: What is the potential of advanced oxidation processes in combatting viral especially SARS-CoV-2? J. Water Process Eng. 2022, 49, 103077. [Google Scholar] [CrossRef] [PubMed]
- Pawrat, J.; Terebun, P.; Kwiatkowski, M.; Tarabová, B.; Kovaľová, Z.; Kučerová, K.; Machala, Z.; Janda, M.; Hensel, K. Evaluation of oxidative species in gaseous and liquid phase generated by mini-gliding arc discharge. Plasma Chem. Plasma Process 2019, 39, 627–642. [Google Scholar] [CrossRef]
- Dobslaw, D.; Schulz, A.; Helbich, S.; Dobslaw, C. VOC removal and odor abatement by a low-cost plasma enhanced bio trickling filter process. J. Environ. Chem. Eng. 2017, 5, 5501–5511. [Google Scholar] [CrossRef]
- Dobslaw, D.; Ortlinghaus, O.; Dobslaw, C. A combined process of non-thermal plasma and a low-cost mineral adsorber for V.O.C. removal and odor abatement in emissions of organic waste treatment plants. J. Environ. Chem. Eng. 2018, 6, 2281–2289. [Google Scholar] [CrossRef]
- Park, C.H.; Byeon, J.H.; Yoon, K.Y.; Park, J.; Hwang, J. Simultaneous removal of odors airborne particles and bioaerosols in a municipal composting facility by dielectric barrier discharge. Sep. Purif. Technol. 2011, 77, 187–193. [Google Scholar] [CrossRef]
- Claus, H. Ozone generation by ultraviolet lamps. Photochem. Photobiol. 2021, 97, 471–476. [Google Scholar] [CrossRef]
- Boelter, K.J.; Davidson, J.H. Ozone generation by indoor electrostatic air cleaners. Aerosol Sci. Technol. 2007, 27, 689–708. [Google Scholar] [CrossRef]
- Caniani, D.; Caivano, M.; Mazzone, G.; Mais, S.; Mancini, I.M. Effect of site-specific conditions and operating parameters on the removal efficiency of petroleum-originating pollutants using ozonation. Sci. Total Environ. 2021, 800, 149393. [Google Scholar] [CrossRef] [PubMed]
- Egorova, G.V.; Voblikova, V.A.; Sabitova, L.V.; Tkachenko, I.S. Ozone solubility in water. Mosc. Univ. Chem. Bull. 2015, 70, 207–210. [Google Scholar] [CrossRef]
- Bayarri, B.; Cruz-Alcalde, A.; Lopez-Vinent, N.; Micó, M.M.; Sans, C. Can ozone inactivate SARS-CoV-2? A review of mechanisms and performance on viruses. J. Hazard. Mater. 2021, 415, 125658. [Google Scholar] [CrossRef] [PubMed]
- Tizaoui, C. Ozone: A potential oxidant for COVID-19 Virus (SARS-CoV-2). Ozone Sci. Eng. 2020, 42, 378–385. [Google Scholar] [CrossRef]
- Skowron, K.; Wałecka-Zacharska, E.; Grudlewska, K.; Białucha, A.; Wiktorczyk, N.; Bartkowska, A.; Kowalska, M.; Kruszewski, S.; Gospodarek-Komkowska, E. Biocidal effectiveness of selected disinfectant solutions based on water and ozonated water against Listeria monocytogenes strains. Microorganisms 2019, 7, 127. [Google Scholar] [CrossRef]
- Erickson, M.C.; Ortega, Y.R. Inactivation of protozoan parasites in food, water, and environmental systems. J. Food Prot. 2006, 26, 2786–2808. [Google Scholar] [CrossRef]
- Epelle, E.I.; Macfarlane, A.; Cusack, M.; Burns, A.; Okolie, J.A.; Mackay, W.; Rateb, M.; Yaseen, M. Ozone application in different industries: A review of recent developments. Chem. Eng. J. 2023, 454, 140188. [Google Scholar] [CrossRef]
- Cai, Y.; Zhao, Y.; Yadav, A.K.; Ji, B.; Kang, P.; Wei, T. Ozone based inactivation and disinfection in the pandemic time and beyond: Taking forward what has been learned and best practice. Sci. Total Environ. 2023, 62, 160711. [Google Scholar] [CrossRef]
- Dubuis, M.E.; Dumont-Leblond, N.; Lalibert’e, C.; Veillette, M.; Turgeon, N.; Jean, J.; Duchaine, C. Ozone efficacy for the control of airborne viruses: Bacteriophage and norovirus models. PLoS ONE 2015, 20, e0231164. [Google Scholar] [CrossRef]
- Cristiano, L. Could ozone be an effective disinfection measure against the novel Coronavirus (SARS-CoV-2)? J. Prev. Med. Hyg. 2020, 61, E301–E303. [Google Scholar] [CrossRef]
- Kong, J.; Lu, Y.; Ren, Y.; Chen, Z.; Chen, M. The virus removal in U.V. irradiation ozonation and chlorination. Water Cycle 2021, 2, 23–31. [Google Scholar] [CrossRef]
- Fehr, A.R.; Perlman, S. Coronaviruses: An overview of their replication and pathogenesis. In Coronaviruses: Methods and Protocols; Maier, H.J., Bickerton, E., Britton, P., Eds.; Humana Press: Totowa, NJ, USA; Springer: New York, NY, USA, 2015; pp. 1–23. [Google Scholar]
- Zhou, P.; Yang, X.; Wang, X.; Hu, B.; Zhang, L.; Zhang, W.; Si, H.R.; Zhu, Y.; Li, B.; Huang, C.L.; et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020, 579, 270–273. [Google Scholar] [CrossRef]
- Murray, B.K.; Ohmine, S.; Tomer, D.P.; Jensen, K.J.; Johnson, F.B.; Kirsi, J.J.; Robison, R.A.; O’Neill, K.L. Virion disruption by ozone-mediated reactive oxygen species. J. Virol. Methods 2008, 153, 74–77. [Google Scholar] [CrossRef]
- Hirneisen, K.A.; Markland, S.M.; Kniel, K.E. Ozone inactivation of norovirus surrogates on fresh produce. J. Food Prot. 2011, 74, 836–839. [Google Scholar] [CrossRef] [PubMed]
- Wolf, C.; Von Gunten, U.; Kohn, T. Kinetics of inactivation of waterborne enteric viruses by ozone. Environ. Sci. Technol. 2018, 52, 2170–2177. [Google Scholar] [CrossRef] [PubMed]
- Li, C.S.; Wang, Y.C. Surface germicidal effects of ozone for microorganisms. AIHAJ Am. Ind. Hyg. Assoc. 2003, 64, 533–537. [Google Scholar] [CrossRef]
- Young, S.; Torrey, J.; Bachmann, V.; Kohn, T. Relationship between inactivation and genome damage of human enteroviruses upon treatment by UV254 free chlorine and ozone. Food Environ. Virol. 2020, 12, 20–27. [Google Scholar] [CrossRef] [PubMed]
- Allison, K.; Hook, J.; Cardis, D.; Rice, R.G. Quantification of the bactericidal fungicidal and sporicidal efficacy of the J.L.A. Ltd ozone laundering system. Ozone Sci. Eng. 2009, 31, 369–378. [Google Scholar] [CrossRef]
- Wigginton, K.R.; Kohn, T. Virus disinfection mechanisms: The role of virus composition structure and function. Curr. Opin. Virol. 2012, 2, 84–89. [Google Scholar] [CrossRef] [PubMed]
- Uppal, T.; Khazaieli, A.; Snijders, A.M.; Verma, S.C. Inactivation of human coronavirus by FATHHOME’s dry sanitizer device: Rapid and eco-friendly ozone-based disinfection of SARS-CoV-2. Pathogens 2021, 10, 339. [Google Scholar] [CrossRef]
- Franke, G.; Knobling, B.; Brill, F.H.; Becker, B.; Klupp, E.M.; Belmar Campos, C.; Pfefferle, S.; Lütgehetmann, M.; Knobloch, J.K. An automated room disinfection system using ozone is highly active against surrogates for SARS-CoV-2. J. Hosp. Infect. 2021, 111, 108–113. [Google Scholar] [CrossRef] [PubMed]
- Yao, M.; Zhang, L.; Ma, J.; Zhou, L. On airborne transmission and control of SARS-CoV-2. Sci. Total Environ. 2020, 73, 139178. [Google Scholar] [CrossRef]
- De Forni, D.; Poddesu, B.; Cugia, G.; Gallizia, G.; La Licata, M.; Lisziewicz, J.; Chafouleas, J.; Lori, F. Low ozone concentration and negative ions for rapid SARS-CoV-2 inactivation. J. Biotechnol. Biomed. 2024, 7, 166. [Google Scholar] [CrossRef]
- Imoto, Y.; Matsui, H.; Ueda, C.; Nakajima, E.; Hanaki, H. Inactivation effects of hypochlorous acid, chlorine dioxide, and ozone on airborne SARS-CoV-2 and influenza A virus. Food Environ. Virol. 2025, 17, 9. [Google Scholar] [CrossRef] [PubMed]
- Torres-Mata, L.B.; García-Pérez, O.; Rodríguez-Esparragón, F.; Blanco, A.; Villar, J.; Ruiz-Apodaca, F.; Martín-Barrasa, J.L.; González-Martín, J.M.; Serrano-Aguilar, P.; Piñero, J.E.; et al. Ozone eliminates SARS-CoV-2 from difficult-to-clean office supplies and clinical equipment. Int. J. Environ. Res. Public Health 2022, 19, 8672. [Google Scholar] [CrossRef]
- Clavo, B.; Cordoba-Lanús, E.; Rodríguez-Esparragon, F.; Cazorla-Rivero, S.E.; García-Pérez, O.; Piñero, J.E.; Villar, J.; Blanco, A.; Torres-Ascensión, C.; Martín-Barrasa, J.L.; et al. Effects of ozone treatment on personal protective equipment contaminated with SARS-CoV-2. Antioxidants 2020, 9, 1222. [Google Scholar] [CrossRef]
- Wolfgruber, S.; Loibner, M.; Puff, M.; Melischnig, A.; Zatloukal, K. SARS-CoV2 neutralizing activity of ozone on porous and nonporous materials. New Biotechnol. 2022, 66, 36–45. [Google Scholar] [CrossRef]
- Choi, E.H.; Uhm, H.S.; Kaushik, N.K. Plasma bioscience and its application to medicine. AAPPS Bull. 2021, 31, 10. [Google Scholar] [CrossRef]
- Choudhury, B.; Lednicky, J.A.; Loeb, J.C.; Portugal, S.; Roy, S. Inactivation of SARS CoV-2 on porous and nonporous surfaces by compact portable plasma reactor. Front. Bioeng. Biotechnol. 2024, 29, 1325336. [Google Scholar] [CrossRef]
- Nakano, R.; Nakano, A.; Sasahara, T.; Suzuki, Y.; Nojima, Y.; Yano, H. Antiviral effects of copper and copper alloy and the underlying mechanisms in severe acute respiratory syndrome coronavirus 2. J. Hazard. Mater. Adv. 2025, 17, 100589. [Google Scholar] [CrossRef]
- Yano, H.; Nakano, R.; Suzuki, Y.; Nakano, A.; Kasahara, K.; Hosoi, H. Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment. J. Hosp. Infect. 2020, 106, 837–838. [Google Scholar] [CrossRef] [PubMed]
- Percivalle, E.; Clerici, M.; Cassaniti, I.; Vecchio Nepita, E.; Marchese, P.; Olivati, D.; Catelli, C.; Berri, A.; Baldanti, F.; Marone, P.; et al. SARS-CoV-2 viability on different surfaces after gaseous ozone treatment: A preliminary evaluation. J. Hosp. Infect. 2021, 110, 33–36. [Google Scholar] [CrossRef] [PubMed]
- Neves, E.S.; Ng, C.T.; Pek, H.B.; Goh, V.S.L.; Mohamed, R.; Osman, S.; Ng, Y.K.; Kadir, S.A.; Nazeem, M.; She, A.; et al. Field trial assessing the antimicrobial decontamination efficacy of gaseous ozone in a public bus setting. Sci. Total Environ. 2023, 876, 162704. [Google Scholar] [CrossRef] [PubMed]
- Frizziero, L.; Donnici, G.; Venditti, G.; Freddi, M. Design of an innovative sanitation system for bike-sharing service. Heliyon 2024, 10, e26595. [Google Scholar] [CrossRef]
- Westover, C.; Rahmatulloev, S.; Danko, D.; Afshin, E.E.; O’Hara, N.B.; Ounit, R.; Bezdan, D.; Mason, C.E. Ozone treatment for elimination of bacteria and SARS-CoV-2 for medical environments. Genes 2022, 14, 85. [Google Scholar] [CrossRef]
- Viana Martins, C.P.; Xavier, C.S.F.; Cobrado, L. Disinfection methods against SARS-CoV-2: A systematic review. J. Hosp. Infect. 2022, 119, 84–117. [Google Scholar] [CrossRef]
- Tizaoui, C.; Stanton, R.; Statkute, E.; Rubina, A.; Lester-Card, E.; Lewis, A.; Holliman, P.; Worsley, D. Ozone for SARS-CoV-2 inactivation on surfaces and in liquid cell culture media. J. Hazard. Mater. 2022, 428, 128251. [Google Scholar] [CrossRef]
- Hu, X.; Chen, Z.; Su, Z.; Deng, F.; Chen, X.; Yang, Q.; Li, P.; Chen, Q.; Ma, J.; Guan, W.; et al. Ozone water is an effective disinfectant for SARS-CoV-2. Virol. Sin. 2021, 36, 1066–1068. [Google Scholar] [CrossRef]
- Corzo-Leon, D.E.; Abbood, H.M.; Colamarinom, R.A.; Steiner, M.F.C.; Munro, C.; Gould, I.M.; Hijazi, K. Methods for SARS-CoV-2 hospital disinfection, in vitro observations. Infect. Prev. Pract. 2024, 6, 100339. [Google Scholar] [CrossRef] [PubMed]
- Takeda, Y.; Jamsransuren, D.; Makita, Y.; Kaneko, A.; Matsuda, S.; Ogawa, H.; Oh, H. Inactivation activities of ozonated water, slightly acidic electrolyzed water and ethanol against SARS-CoV-2. Molecules 2021, 26, 5465. [Google Scholar] [CrossRef]
- Yasugi, M.; Gunji, K.; Inagaki, K.; Kuroda, M.; Ii, C. Disinfection effect of ozonated water on SARS-CoV-2 in the presence of salivary proteins. J. Hosp. Infect. 2025, 155, 209–215. [Google Scholar] [CrossRef] [PubMed]
- Volkoff, S.J.; Carlson, T.J.; Leik, K.; Smith, J.J. Demonstrated SARS-CoV-2 surface disinfection using ozone. Ozone Sci. Eng. 2021, 43, 296–305. [Google Scholar] [CrossRef]
- Murata, T.; Komoto, S.; Iwahori, S.; Sasaki, J.; Nishitsuji, H.; Hasebe, T.; Hoshinaga, K.; Yuzawa, Y. Reduction of severe acute respiratory syndrome Coronavirus-2 infectivity by admissible concentration of ozone gas and water. Microbiol. Immunol. 2021, 65, 10–16. [Google Scholar] [CrossRef]
- Nishiki, Y.; Imazu, T.; Nakamuro, K.; Naitou, H.; Aoki, K.J. Inactivation mechanism of SARS-CoV-2 by ozone in aqueous and gas phases. J. Microorg. Control 2023, 28, 43–48. [Google Scholar] [CrossRef] [PubMed]
- Sallustio, F.; Cardinale, G.; Voccola, S.; Picerno, A.; Porcaro, P.; Gesualdo, L. Ozone eliminates novel coronavirus SARS-CoV-2 in mucosal samples. New Microbes New Infect. 2021, 43, 100927. [Google Scholar] [CrossRef] [PubMed]
- Nicolo, M.S.; Rizzo, M.G.; Palermo, N.; Gugliandolo, C.; Cuzzocrea, S.; Guglielmino, S.P.P. Evaluation of betacoronavirus OC43 and SARS-CoV-2 elimination by zefero air sanitizer device in a novel laboratory recirculation system. Pathogens 2022, 11, 221. [Google Scholar] [CrossRef] [PubMed]
- Diella, G.; Caggiano, G.; Apollonio, F.; Triggiano, F.; Stefanizzi, P.; Fasano, F.; Pace, L.; Marcotrigiano, V.; Sorrenti, D.P.; Sorrenti, G.T.; et al. SARS-CoV-2 RNA viability on high-touch surfaces and evaluation of a continuous-flow ozonation treatment. Ann. Ig. 2023, 35, 112–120. [Google Scholar] [CrossRef] [PubMed]
- Córdoba-Lanús, E.; García-Pérez, O.; Rodríguez-Esparragón, F.; Bethencourt-Estrella, C.J.; Torres-Mata, L.B.; Blanco, A.; Villar, J.; Sanz, O.; Díaz, J.J.; Martín-Barrasa, J.L.; et al. Ozone treatment effectively eliminates SARS-CoV-2 from infected face masks. PLoS ONE 2022, 17, e0271826. [Google Scholar] [CrossRef] [PubMed]

| Material/Substrate | Ambient Conditions | Operational |
|---|---|---|
| Temperature | Material shape and porosity | Ozone concentration |
| pH | Contact angle | Ozonation duration |
| Conductivity | Contamination method | Ozone generation method |
| Relative humidity | Level of microbial contamination | Penetrability |
| Pressure | Surface chemical composition | Radical generation (OH•) |
| Dissolved concentration organic matter | Concentration homogenization |
| Ozonation Phase | Ozone-Based Device | Ozone Concentration | Exposure Time | Virus Type | Material/Substrate | Summary of Findings | Ref. |
|---|---|---|---|---|---|---|---|
| Aqueous | Industrial ozone generator (Grenof, Brisbane, Australia). | 0.375 ppm, 0.75 ppm, 1 ppm | 5 min | SARS-CoV-2, QLD02 (GISAID accession EPI_ISL_407,896) and QLD935 (GISAID accession EPI_ISL_436,097) | Cell line and virus isolates | 0.75 ppm aqueous ozone is highly effective in inactivating the virus after 5 min of incubation, with 0.375 ppm achieving 82–91.5% inactivation. | [27] |
| Aqueous | DOCOL® | 0.2–0.8 ppm | 1 min | SARS-Cov-2 in Vero CCL81 lineage | Virus solution | A reduction in virus infectivity was observed after a 0.6 ppm ozone treatment for 1 min, corresponding to a 2 log10 reduction. | [38] |
| Aqueous | ND | 4.5, 9, 18, 36 ppm | 1, 5, 10 min | SARS-CoV-2 in Vero E6 cell line | Viral solution | 36 ppm aqueous ozonation fully inactivated the virus stock in <1 min. | [92] |
| Aqueous | Electrolytic ozone water-generating device (Handlex, ONR-1, Nikkiso/Nikkamicron Co., Saitama/Tokyo, Japan) | 4, 7, 10 ppm | 1, 5–20 s | SARS-CoV-2/Hu/D.P./Kng/19-027, LC528233 | Viral stock solution | Virus titer reduction rates after 5 s treatment with ozone concentrations of 1, 4, 7, and 10 ppm were 81.4%, 93.2%, 96.6%, and 96.6%, respectively. | [39] |
| Aqueous | Ozonated water | 7 ppm O3 solution was mixed with the virus (9:1 volume ratio) | 3 min and 10 min | Three SARS-CoV-2 variants of concern (WHO label alpha, beta, gamma; Pango lineage B.1.1.7, B.1.351, P.1) in Vero E6 cells (ATCC-CRL1586) | Viral solution | Reduction in the viral activity of <1 log | [94] |
| Aqueous | Ozone water-generating device (Panasonic, Tokyo, Japan) | 1.5 mg/L | 5 min | SARS-CoV-2 in Vero E6 cell line | SARS-CoV-2 in saliva | Ozonated water appeared to inactivate SARS-CoV-2 within 30 s. The amount of inactivated SARS-CoV-2 decreased as the protein concentration increased. Virus inactivation was stronger by 1.5 mg/L ozonated water than by 0.5 mg/L ozonated water. | [96] |
| Gaseous and Aqueous | STERISAFE Pro version 1.0, STERISAFE ApS, Ole Maaløe’s vej 5, DK-2200 Copenhagen, Denmark | 0.5–20 g·min/m3 | 3, 5, 20 min | Bacteriophage F6 and BCoV | Stainless steel, copper, plastic, glass, coupons of ambulance seats, and flooring | 15 g/min/m3 ozone and 81% R.H., a reduction of up to 2 logs was observed on stainless steel and glass. A constant inactivation rate for the liquid was 7 × 105 M−1 s−1. | [92] |
| Gaseous/Aqueous | Sanozone™ O3 generator (Sanozone, Regina, SK, Canada) | 4.5 and 9 ppm | 10–90 min | Recombinant mammalian cell product, bacteriophage MS2, and SARS-CoV-2 | Polyester, stainless steel, plastic, and paper. Water treatment was also performed | After 4.5 and 9 ppm ozone exposure for 60–90 min, no virus RNA was recovered from plastic surfaces | [97] |
| Gaseous/Aqueous | Ozone gas and L CLEAN Minnie (Tamura TECO Co., Ltd., Higashiosaka City, Japan) | 0.05–2 ppm | 10 s–20 h | SARS-Cov-2 in VeroE6/TMPRSS2 cells | Stainless steel for gaseous exposure and viral solutions. | 0.05 and 0.1 ppm ozone gas treatment decreased virus infectivity by ~95% in 10 and 20 h, depending on R.H. 1 and 2 mg/L ozonated water treatment reduced virus infectivity by about 2 and 3 logs in 10 s | [98] |
| Gaseous and Aqueous | Ozone-gas generator (MXAP-AE270, Maxell Ltd., Tokyo, Japan) and Ozonated water generator (MXZW-WM100J, Maxell Ltd., ejector type | 0.05 ppmv and 0.2 mg/L | 12–24 h and 30 s and 60 s | SARS-CoV-2; 2019-nCoV JPN/TY/WK-521 strain | Viral solution | Inactivation in the gas phase requires 1014–1015 ozone molecules per virus virion, while the inactivation in the aqueous phase requires 5 × 1010 to 5 × 1011 ozone molecules | [99] |
| Gaseous | ICON3 device | 0–5.5 ppm | 0–45 min | SARS-CoV-2 in Vero E6 cells (kidney epithelial cells from African green monkey, ATCC CRL-1586) | Virus suspensions in well plates | 3.18 ppm of ozone inactivated > 99% of the virus within 20 min. | [78] |
| Gaseous | Medical ozone generator (Ozonobaric P®, Sedecal, Madrid, Spain) | 19, 33, 70, and 90 ppm 2000, 4000, 10,000 ppm | 30, 60, 90, and 120 min 5, 10 min | SARS-CoV-2 strain 2019-nCoV/USA-WA1/2020 | Office supplies (personal computer monitors, keyboards, and mice) and clinical equipment (continuous positive airway pressure tubes and PPE) | 4000 ppm ozone eliminated viral RNA within 10 min | [80] |
| Gaseous | Medical ozone generators (Ozonobaric P®, Sedecal, Madrid, Spain) | 4–12 ppm 500–40,000 ppm | 0.5, 1, 5, 10 min | SARS-CoV-2 strain 2019-nCoV/USA-WA1/2020 | PPE gowns and facemasks | No viral amplification was detected after ozone exposure (2000 ppm or higher). At lower concentrations (4–12 ppm), inactivation depended on R.H. | [81] |
| Gaseous | Plasma generator (CeraPlas™ element, Relyon Plasma GmbH, Regensburg, Germany) | 800 ppm | 10–60 min | SARS-CoV-2 virus isolate (Human 2019-nCoV Isolate ex China Strain: BavPat1/2020) | Cotton facemasks, FFP3 facemasks, glass slides | 800 ppm ozone exposure within 10–60 min demonstrated >6 log reduction | [82] |
| Gaseous | DBD plasma | 120 ppm with power 13 W | 10–300 s | HCoV-229E | Face mask-94 (KF94) | Reduce the viral RNA load to 4 log orders with an ozone concentration of 120 ppm, exposed for 10 s | [83] |
| Gaseous | Device generating ozone gas (TM-04OZ; Tamura TECO Ltd., Higashiosaka City, Osaka, Japan) | 1, 6 ppm | 55, 60 min | SARS-CoV-2 (JPN/TY/WK-521) strain in VeroE6/TMPRSS2 cells (JCRB1819) | Stainless steel | A 6 ppm ozone gas exposure for 55 min yielded a 3 log10 reduction (PFU/mL) in viral load. | [38] |
| Gaseous | ND | 0.5, 1, 2 ppm | 40, 60 min | SARS-CoV-2 | Painted aluminum, non-painted aluminum, FFP2 masks, glass, plastic, surgical gown, Plexiglas, stainless steel | In 60 min, ~85–90% viability reduction on all surfaces at all concentrations | [88] |
| Gaseous | Sani Suport Supreme | 20 ppm | 30 min, 1 h, 2 h, 3 h, 4 h | Twist synthetic SARS-CoV-2 RNA. | Blankets, remotes, catheters, and syringes | At 240 min, ~99% capsid RNA was degraded | [28] |
| Gaseous | Ozonext Defender 10 (Cea S.p.A., Lecco, Italy) | 0.2 and 4 ppm | 30–120 min | hCoV-19/Italy/UniSR1/2020 (GISAID accession ID: EPI_ISL_413489) in Vero E6 cells | Wood, gauze, fleece, glass, and plastic | 4 ppm ozone exposure within 30 min yielded a 90% reduction in viral titers for all materials | [91] |
| Gaseous | Bio3gen apparatus (Finlinea s.p.a., Gazzaniga, Bergamo, Italy) | 400 mg/h 3.6 L/min | 4 min | SARS-CoV-2 | Swabs | The real-time detection kit tested negative | [100] |
| Gaseous | Air sanitizer “Zefero” (Cf7 S.r.l., S. Giovanni La Punta, Catania, Italy) | 5 g/h in a chamber of 0.033 m3 | 15, 30 min | Betacoronavirus OC43 and SARS-CoV-2 | Aerosol sampling | After 30 min of ozone exposure, the virus was fully eliminated. | [101] |
| Gaseous | Ozonization system (model GX, Ozotek®, Taranto, Italy) | 2.64 g/h | 2 h 30 min | SARS-CoV-2 isolation in Vero E6 cell line (African green monkey kidney cells) | Supermarket (scales, refrigerator handles, shopping trolley handles, cash register keyboards, and P.O.S. keyboards) | There is no statistically significant difference between supermarkets with and without an ozonation system. | [102] |
| Gaseous | Ozone generator (Ozonobaric P1, Sedecal, Madrid, Spain) | 2000, 4000, and 10,000 ppm | 1, 2, 5, and 10 min | SARS-CoV-2 in VERO E6 cells (ATCC CRL-1586) | Face masks, viral solution | The best-evaluated option in this study was 4000 ppm (8 g/m3) for 2 min. | [103] |
| Gaseous | Ozone gas generator (Mitsubishi Heavy Industries, Ltd., Tokyo, Japan). | 0.1, 0.3, and 1.0 ppm | 0 min, 100 s, 5 min, and 10 min | SARS-CoV-2 strain 2019-nCoV/Japan/TY/WK-521/2020 in VeroE6/TEMPRESS2 cells (JCRB1819) | A mixed sample of SARS-CoV-2 and influenza A virus in diluted saliva | The concentrations of ozone in the air reached a 2 log reduction in SARS-CoV-2 infectivity titer within 10 min at 1.0 ppm. | [79] |
| Gaseous | Compact Portable Plasma Reactor (CPPR) | 1 ppm | 5–15 min | SARS-CoV-2 strain UF-1 and HCoV-OC43 strain JAL-1 in Vero E6 cells | SARS-CoV-2 and HCoV-OC43 on representative porous (KN95 mask material) and nonporous materials (aluminum and polycarbonate) | Minimum CPPR exposure times of 5–15 min resulted in a 4–5 log reduction in SARS-CoV-2 and its surrogate on representative material samples. | [84] |
| Gaseous | Virestorm V5 ozone generator | Between 13 and 18 ppm | 55, 85, and 210 min | Murine hepatitis virus (MHV-a related betacoronavirus surrogate) and Staphylococcus aureus | Carriers-Stainless steel disks | 3.65 log reduction in murine hepatitis virus and a 4.73 log decrease in S. aureus | [89] |
| Glycerol | Ozonizer (Mediplus Co., Tokyo, Japan) | 20, 200, 500, and 1000 ppm | 20 s, 1 h, and 24 h | SARS-CoV-2 (JPN/TY/WK-521 strain) in VeroE6/TMPRSS2 cells (cell number: JCRB1819) | Viral solution | 500 ppm ozonated glycerol at 20% of F.B.S. concentration for 1 h was ≥99.91% of virus inactivation | [95] |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Rangel, K.; Villas-Bôas, M.H.S.; De-Simone, S.G. Advances in Ozone-Based Inactivation of SARS-CoV-2: An Updated Review. Int. J. Mol. Sci. 2026, 27, 3632. https://doi.org/10.3390/ijms27083632
Rangel K, Villas-Bôas MHS, De-Simone SG. Advances in Ozone-Based Inactivation of SARS-CoV-2: An Updated Review. International Journal of Molecular Sciences. 2026; 27(8):3632. https://doi.org/10.3390/ijms27083632
Chicago/Turabian StyleRangel, Karyne, Maria Helena Simões Villas-Bôas, and Salvatore Giovanni De-Simone. 2026. "Advances in Ozone-Based Inactivation of SARS-CoV-2: An Updated Review" International Journal of Molecular Sciences 27, no. 8: 3632. https://doi.org/10.3390/ijms27083632
APA StyleRangel, K., Villas-Bôas, M. H. S., & De-Simone, S. G. (2026). Advances in Ozone-Based Inactivation of SARS-CoV-2: An Updated Review. International Journal of Molecular Sciences, 27(8), 3632. https://doi.org/10.3390/ijms27083632

